Global Rotavirus Infection Therapeutics Market Research Report 2023

Report ID: 1891900 | Published Date: Oct 2024 | No. of Page: 85 | Base Year: 2023 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Rotavirus Infection Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Oral Drug
        1.2.3 Injiectable Drug
    1.3 Market by Application
        1.3.1 Global Rotavirus Infection Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Rotavirus Infection Therapeutics Market Perspective (2017-2028)
    2.2 Rotavirus Infection Therapeutics Growth Trends by Region
        2.2.1 Rotavirus Infection Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Rotavirus Infection Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Rotavirus Infection Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Rotavirus Infection Therapeutics Market Dynamics
        2.3.1 Rotavirus Infection Therapeutics Industry Trends
        2.3.2 Rotavirus Infection Therapeutics Market Drivers
        2.3.3 Rotavirus Infection Therapeutics Market Challenges
        2.3.4 Rotavirus Infection Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Rotavirus Infection Therapeutics Players by Revenue
        3.1.1 Global Top Rotavirus Infection Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Rotavirus Infection Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Rotavirus Infection Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Rotavirus Infection Therapeutics Revenue
    3.4 Global Rotavirus Infection Therapeutics Market Concentration Ratio
        3.4.1 Global Rotavirus Infection Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Rotavirus Infection Therapeutics Revenue in 2021
    3.5 Rotavirus Infection Therapeutics Key Players Head office and Area Served
    3.6 Key Players Rotavirus Infection Therapeutics Product Solution and Service
    3.7 Date of Enter into Rotavirus Infection Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Rotavirus Infection Therapeutics Breakdown Data by Type
    4.1 Global Rotavirus Infection Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Rotavirus Infection Therapeutics Forecasted Market Size by Type (2023-2028)
5 Rotavirus Infection Therapeutics Breakdown Data by Application
    5.1 Global Rotavirus Infection Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Rotavirus Infection Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Rotavirus Infection Therapeutics Market Size (2017-2028)
    6.2 North America Rotavirus Infection Therapeutics Market Size by Country (2017-2022)
    6.3 North America Rotavirus Infection Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Rotavirus Infection Therapeutics Market Size (2017-2028)
    7.2 Europe Rotavirus Infection Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Rotavirus Infection Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Rotavirus Infection Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Rotavirus Infection Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Rotavirus Infection Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Rotavirus Infection Therapeutics Market Size (2017-2028)
    9.2 Latin America Rotavirus Infection Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Rotavirus Infection Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Rotavirus Infection Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Rotavirus Infection Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Rotavirus Infection Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 GlaxoSmithKline
        11.1.1 GlaxoSmithKline Company Detail
        11.1.2 GlaxoSmithKline Business Overview
        11.1.3 GlaxoSmithKline Rotavirus Infection Therapeutics Introduction
        11.1.4 GlaxoSmithKline Revenue in Rotavirus Infection Therapeutics Business (2017-2022)
        11.1.5 GlaxoSmithKline Recent Development
    11.2 Bharat Biotech
        11.2.1 Bharat Biotech Company Detail
        11.2.2 Bharat Biotech Business Overview
        11.2.3 Bharat Biotech Rotavirus Infection Therapeutics Introduction
        11.2.4 Bharat Biotech Revenue in Rotavirus Infection Therapeutics Business (2017-2022)
        11.2.5 Bharat Biotech Recent Development
    11.3 Curevac
        11.3.1 Curevac Company Detail
        11.3.2 Curevac Business Overview
        11.3.3 Curevac Rotavirus Infection Therapeutics Introduction
        11.3.4 Curevac Revenue in Rotavirus Infection Therapeutics Business (2017-2022)
        11.3.5 Curevac Recent Development
    11.4 Ology Bioservices
        11.4.1 Ology Bioservices Company Detail
        11.4.2 Ology Bioservices Business Overview
        11.4.3 Ology Bioservices Rotavirus Infection Therapeutics Introduction
        11.4.4 Ology Bioservices Revenue in Rotavirus Infection Therapeutics Business (2017-2022)
        11.4.5 Ology Bioservices Recent Development
    11.5 BioKangtai
        11.5.1 BioKangtai Company Detail
        11.5.2 BioKangtai Business Overview
        11.5.3 BioKangtai Rotavirus Infection Therapeutics Introduction
        11.5.4 BioKangtai Revenue in Rotavirus Infection Therapeutics Business (2017-2022)
        11.5.5 BioKangtai Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Rotavirus Infection Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Oral Drug
    Table 3. Key Players of Injiectable Drug
    Table 4. Global Rotavirus Infection Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Rotavirus Infection Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Rotavirus Infection Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Rotavirus Infection Therapeutics Market Share by Region (2017-2022)
    Table 8. Global Rotavirus Infection Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Rotavirus Infection Therapeutics Market Share by Region (2023-2028)
    Table 10. Rotavirus Infection Therapeutics Market Trends
    Table 11. Rotavirus Infection Therapeutics Market Drivers
    Table 12. Rotavirus Infection Therapeutics Market Challenges
    Table 13. Rotavirus Infection Therapeutics Market Restraints
    Table 14. Global Rotavirus Infection Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Rotavirus Infection Therapeutics Market Share by Players (2017-2022)
    Table 16. Global Top Rotavirus Infection Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rotavirus Infection Therapeutics as of 2021)
    Table 17. Ranking of Global Top Rotavirus Infection Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Rotavirus Infection Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Rotavirus Infection Therapeutics Product Solution and Service
    Table 21. Date of Enter into Rotavirus Infection Therapeutics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Rotavirus Infection Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Rotavirus Infection Therapeutics Revenue Market Share by Type (2017-2022)
    Table 25. Global Rotavirus Infection Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Rotavirus Infection Therapeutics Revenue Market Share by Type (2023-2028)
    Table 27. Global Rotavirus Infection Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Rotavirus Infection Therapeutics Revenue Market Share by Application (2017-2022)
    Table 29. Global Rotavirus Infection Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Rotavirus Infection Therapeutics Revenue Market Share by Application (2023-2028)
    Table 31. North America Rotavirus Infection Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Rotavirus Infection Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Rotavirus Infection Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Rotavirus Infection Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Rotavirus Infection Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Rotavirus Infection Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Rotavirus Infection Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Rotavirus Infection Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Rotavirus Infection Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Rotavirus Infection Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. GlaxoSmithKline Company Detail
    Table 42. GlaxoSmithKline Business Overview
    Table 43. GlaxoSmithKline Rotavirus Infection Therapeutics Product
    Table 44. GlaxoSmithKline Revenue in Rotavirus Infection Therapeutics Business (2017-2022) & (US$ Million)
    Table 45. GlaxoSmithKline Recent Development
    Table 46. Bharat Biotech Company Detail
    Table 47. Bharat Biotech Business Overview
    Table 48. Bharat Biotech Rotavirus Infection Therapeutics Product
    Table 49. Bharat Biotech Revenue in Rotavirus Infection Therapeutics Business (2017-2022) & (US$ Million)
    Table 50. Bharat Biotech Recent Development
    Table 51. Curevac Company Detail
    Table 52. Curevac Business Overview
    Table 53. Curevac Rotavirus Infection Therapeutics Product
    Table 54. Curevac Revenue in Rotavirus Infection Therapeutics Business (2017-2022) & (US$ Million)
    Table 55. Curevac Recent Development
    Table 56. Ology Bioservices Company Detail
    Table 57. Ology Bioservices Business Overview
    Table 58. Ology Bioservices Rotavirus Infection Therapeutics Product
    Table 59. Ology Bioservices Revenue in Rotavirus Infection Therapeutics Business (2017-2022) & (US$ Million)
    Table 60. Ology Bioservices Recent Development
    Table 61. BioKangtai Company Detail
    Table 62. BioKangtai Business Overview
    Table 63. BioKangtai Rotavirus Infection Therapeutics Product
    Table 64. BioKangtai Revenue in Rotavirus Infection Therapeutics Business (2017-2022) & (US$ Million)
    Table 65. BioKangtai Recent Development
    Table 66. Research Programs/Design for This Report
    Table 67. Key Data Information from Secondary Sources
    Table 68. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Rotavirus Infection Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Oral Drug Features
    Figure 3. Injiectable Drug Features
    Figure 4. Global Rotavirus Infection Therapeutics Market Share by Application in 2021 & 2028
    Figure 5. Hospital Pharmacies Case Studies
    Figure 6. Retail Pharmacies Case Studies
    Figure 7. Online Pharmacies Case Studies
    Figure 8. Rotavirus Infection Therapeutics Report Years Considered
    Figure 9. Global Rotavirus Infection Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Rotavirus Infection Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Rotavirus Infection Therapeutics Market Share by Region: 2021 VS 2028
    Figure 12. Global Rotavirus Infection Therapeutics Market Share by Players in 2021
    Figure 13. Global Top Rotavirus Infection Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rotavirus Infection Therapeutics as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Rotavirus Infection Therapeutics Revenue in 2021
    Figure 15. North America Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Rotavirus Infection Therapeutics Market Share by Country (2017-2028)
    Figure 17. United States Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Rotavirus Infection Therapeutics Market Share by Country (2017-2028)
    Figure 21. Germany Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Rotavirus Infection Therapeutics Market Share by Region (2017-2028)
    Figure 29. China Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Rotavirus Infection Therapeutics Market Share by Country (2017-2028)
    Figure 37. Mexico Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Rotavirus Infection Therapeutics Market Share by Country (2017-2028)
    Figure 41. Turkey Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Rotavirus Infection Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. GlaxoSmithKline Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2017-2022)
    Figure 44. Bharat Biotech Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2017-2022)
    Figure 45. Curevac Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2017-2022)
    Figure 46. Ology Bioservices Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2017-2022)
    Figure 47. BioKangtai Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2017-2022)
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline
Bharat Biotech
Curevac
Ology Bioservices
BioKangtai
Frequently Asked Questions
Rotavirus Infection Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Rotavirus Infection Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Rotavirus Infection Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Syphilis Diagnosis

Syphilis Diagnosis market is segmented by players, region (country), by Type and by Application.  ... Read More